Speaker
Ana María Guzmán Jiménez
(Universidad de Costa Rica)
Summary
Laboratories dedicated to the production of radiopharmaceuticals for positron emission tomography (PET) play a critical role in modern nuclear medicine by providing essential inputs for the early detection and monitoring of various pathologies. Given the highly specialized and sensitive nature of these processes which involve the handling of radioactive materials and chemical synthesis under controlled conditions it is imperative to implement a robust and regulatory-aligned quality management system. In this context, the ISO/IEC 17025 standard offers a fundamental framework to ensure technical competence, result traceability, patient safety, and continuous improvement.
Author
Barbara Duran Jimenez
(Universidad de Costa Rica)
Co-authors
Ana María Guzmán Jiménez
(Universidad de Costa Rica)
Luis Roberto Solís Alfaro
(Universidad de Costa Rica)
Monica Diaz Quesada